CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

Go back to CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
CalAmp Corp. (NASDAQ: CAMP) Delayed: 4.48 +0.02 (0.45%)
Previous Close $4.46    52 Week High $21.34 
Open $4.50    52 Week Low $12.13 
Day High $4.54    P/E 3.37 
Day Low $4.42    EPS $1.33 
Volume 126,863